Provista Life Sciences is Bioscience Company of the Year.Provista Life Sciences Named the Bioscience Company Who Did the Most to Transform the World During the Last 12 Months
PHOENIX -- Provista Life Sciences was honored as the winner of the Arizona BioIndustry Association (AZBio) 2008 Bioscience Company of the Year Award, at AZBio's annual dinner on Sept. 18 in Tempe, Ariz. Attended by more than 400 people, AZBio presented six awards, recognizing the best in Arizona bioscience.
Will Gartner, the company's President & CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. who accepted the award on behalf of Provista, said, "We are extremely proud to receive this award from AZBio, as it demonstrates the success of our efforts to improve diagnostics, and our commitment to technology, innovation and saving lives." In March 2008, Provista introduced to the market the BT Test([R]), an innovative diagnostic blood test for the early detection of breast cancer.
The BT Test, or Biomarker biomarker /bio·mark·er/ (bi´o-mahr?ker)
1. a biological molecule used as a marker for a substance or process of interest.
2. tumor marker.
1. Translation Test, finds multiple cancer-related proteins in the blood and combines the results with the patient's medical profile to help physicians in their efforts to find breast cancer as early as possible. Clinical research conducted on the BT Test showed an accuracy rate above 80 percent. When used in conjunction with mammography mammography, diagnostic procedure that uses low-dose X rays to detect abnormalities in the breasts. The early diagnosis of breast cancer made possible by the routine use of mammography for screening women increases a woman's treatment alternatives and improves her screening and other diagnostic imaging procedures, the BT Test offers women a more comprehensive and cost-effective means to screen for breast cancer.
In addition to the release of the BT Test for breast cancer, Provista is completing a clinical study for a blood test for Alzheimer's disease Alzheimer's disease (ăls`hī'mərz, ôls–), degenerative disease of nerve cells in the cerebral cortex that leads to atrophy of the brain and senile dementia. called the LymPro Test([R]). The LymPro Test is a breakthrough blood test designed to work in conjunction with traditional diagnostic methods to help doctors develop a more timely and accurate diagnosis of Alzheimer's disease. Provista Life Sciences is dedicated to advancing diagnostic technology for Central Nervous System diseases, with a specific goal of improving the care and quality of life for people suffering from memory loss and cognitive impairment Impairment
1. A reduction in a company's stated capital.
2. The total capital that is less than the par value of the company's capital stock.
1. This is usually reduced because of poorly estimated losses or gains.
Provista Life Sciences' Background
Provista Life Sciences was established in 2006 as a biotechnology development and commercialization organization that provides the scientific and operating management resources to rapidly advance the development and introduction of novel diagnostics technologies into the domestic and global marketplace. For more information, visit the company's web site at www.provistals.com or call 602-224-5500.
Arizona BioIndustry Association
The Arizona BioIndustry Association is a not-for-profit trade association that seeks to unify 1. (database, product) Unify - A relational database produced by Unify Corporation.
2. (algorithm) unify - To perform unification. , empower and advance its member organizations, who collectively form Arizona's bioscience community, and to make Arizona a place where bioscience companies can grow and succeed. AZBio is the state affiliate in Arizona for both the Biotechnology Industry Organization Biotechnology Industry Organization or BIO was founded 1993 in Washington, DC. James C. Greenwood is BIO's current President. External links
Superior to or notable above all others; outstanding. See Synonyms at dominant, noted.
[Middle English, from Latin prae trade association for the biotechnology industry in the United States United States, officially United States of America, republic (2005 est. pop. 295,734,000), 3,539,227 sq mi (9,166,598 sq km), North America. The United States is the world's third largest country in population and the fourth largest country in area. , and AdvaMed, a national trade association whose members produce nearly 90 percent of the health care technology purchased annually in the United States.